10.29.23
Vitamin C serums and retinol have become the new staple in beauty enthusiasts’ medicine cabinets. But being that exploration and experimentation is all the hype in skincare, treatments are seeing a lift in popularity according to beauty trend tracker Spate.
Currently, the top growing skincare trends in US searches are for treatments are Aviclear laser and non-invasive facelifts.
Acne Zapper
Aviclear laser is the first FDA-approved laser treatment for those with mild to severe acne. It’s often referred to as a great alternative to Accutane; the top-related search is “near me” alongside “Aviclear,” which tells analysts that consumers know what the treatment is, are looking to try the treatment out and want to find providers near them.
Consumers are also searching for reviews, as well as “before and after” comparisons, which shows that they want to know what they’re getting into and whether or not it’s worth the high price tag. Not only does this offer an opportunity for dermatologists to educate through content (also known as the “dermfluencer”), but there’s also a lot of opportunity for brands to highlight products that can help the skin heal post-treatment or to release new post-care products.
Forgoing the Knife
For those looking to forgo the knife, non-invasive facelifts are a viable option. Currently, there’s no competition, with Emface being the sole market leader. Consumers are looking to Emface, the treatment that contracts facial muscles with electromagnetic energy to lift, tone, sculpt and create the appearance of a facelift. However, there is a variety of non-invasive facelift treatments to choose from – all with the primary objective of lifting sagging areas of the face sans the need for sedation or a hospital stay.
Top volume formats such as threading, procedure, treatment and machine emphasize the range of options consumers are researching. Questions like “the best?” and “what is?” reflect consumers’ interest in educating themselves about non-invasive facelifts. It’s important to note that, while these treatments are less invasive, they still cost a pretty penny and may require some downtime, analysts say.